1. Home
  2. SYRE vs BBSI Comparison

SYRE vs BBSI Comparison

Compare SYRE & BBSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYRE
  • BBSI
  • Stock Information
  • Founded
  • SYRE 2013
  • BBSI 1965
  • Country
  • SYRE United States
  • BBSI United States
  • Employees
  • SYRE N/A
  • BBSI N/A
  • Industry
  • SYRE Biotechnology: Pharmaceutical Preparations
  • BBSI Professional Services
  • Sector
  • SYRE Health Care
  • BBSI Consumer Discretionary
  • Exchange
  • SYRE Nasdaq
  • BBSI Nasdaq
  • Market Cap
  • SYRE 1.2B
  • BBSI 1.1B
  • IPO Year
  • SYRE 2016
  • BBSI 1993
  • Fundamental
  • Price
  • SYRE $16.14
  • BBSI $41.15
  • Analyst Decision
  • SYRE Strong Buy
  • BBSI Buy
  • Analyst Count
  • SYRE 8
  • BBSI 3
  • Target Price
  • SYRE $51.50
  • BBSI $41.67
  • AVG Volume (30 Days)
  • SYRE 661.8K
  • BBSI 133.7K
  • Earning Date
  • SYRE 05-08-2025
  • BBSI 04-30-2025
  • Dividend Yield
  • SYRE N/A
  • BBSI 0.77%
  • EPS Growth
  • SYRE N/A
  • BBSI 7.03
  • EPS
  • SYRE N/A
  • BBSI 1.98
  • Revenue
  • SYRE N/A
  • BBSI $1,144,531,000.00
  • Revenue This Year
  • SYRE N/A
  • BBSI $9.65
  • Revenue Next Year
  • SYRE N/A
  • BBSI $7.57
  • P/E Ratio
  • SYRE N/A
  • BBSI $20.87
  • Revenue Growth
  • SYRE N/A
  • BBSI 7.04
  • 52 Week Low
  • SYRE $16.13
  • BBSI $28.42
  • 52 Week High
  • SYRE $40.84
  • BBSI $44.97
  • Technical
  • Relative Strength Index (RSI)
  • SYRE 35.24
  • BBSI 52.71
  • Support Level
  • SYRE $16.71
  • BBSI $40.77
  • Resistance Level
  • SYRE $18.28
  • BBSI $42.28
  • Average True Range (ATR)
  • SYRE 1.21
  • BBSI 0.79
  • MACD
  • SYRE -0.03
  • BBSI 0.22
  • Stochastic Oscillator
  • SYRE 0.15
  • BBSI 65.55

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

About BBSI Barrett Business Services Inc.

Barrett Business Services Inc is a provider of payroll administrative services and staffing services. The company categories of services include professional employer services and staffing. Professional employer services offer payroll management, payroll tax services, and workers' compensation coverage solutions, as well as workforce management services, including hiring and termination of employees. Staffing offers temporary staffing services, as well as contract staffing, long-term or indefinite on-site management, and direct placement services. The company operates in the United States of America. It generates maximum revenue from the Professional employer service fees.

Share on Social Networks: